JE
GILD icon

JMAC Enterprises’s Gilead Sciences GILD Stock Holding History

JMAC Enterprises’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$390K Sell
2,800
-500
-15% -$70K 0.07% 101
2025
Q4 		$405K Buy
+3,300
New +$401K 0.08% 98
2022
Q4 		– Sell
-10,050
Closed -$620K – 178
2022
Q3 		$620K Buy
10,050
+1,000
+11% +$63.1K 0.17% 111
2022
Q2 		$559K Buy
9,050
+200
+2% +$12.4K 0.14% 119
2022
Q1 		$526K Hold
8,850
– – 0.12% 123
2021
Q4 		$565K Buy
+8,850
New +$610K 0.13% 118

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JMAC Enterprises's GILD Position: Q1 2026 in Review

JMAC Enterprises reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $70K and leaving 2,800 shares worth $390K. The position accounts for 0.07% of the portfolio, ranked #101.

JMAC Enterprises first reported a position in GILD in Q4 2021 and has held it in 6 quarters since. The position peaked at $620K in Q3 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • JMAC Enterprises held 2,800 shares of Gilead Sciences worth $390K as of Q1 2026.
  • JMAC Enterprises sold 500 Gilead Sciences shares in Q1 2026, an estimated $70K.
  • Gilead Sciences made up 0.07% of JMAC Enterprises's portfolio in Q1 2026, its #101 holding.
  • JMAC Enterprises first reported a position in Gilead Sciences in Q4 2021 and has held it in 6 quarters since.
  • JMAC Enterprises's Gilead Sciences position peaked at $620K in Q3 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on JMAC Enterprises's 13F filing for Q1 2026, filed 1 May 2026.